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A renewed call for transdisciplinary action
on NCDs
Brigit Toebes1*, Marlies Hesselman2, Jochen O. Mierau3 and Jitse P. van Dijk4
Abstract
Notwithstanding COVID-19, non-communicable diseases (NCDs) will be the leading cause of death in every region
in the world by 2030. This contribution, which forms an introduction to our collection of articles in this journal,
identifies elements for a transdisciplinary research agenda between law, public health, health economics and
international relations aimed at designing concrete interventions to curb the NCD pandemic, both globally and
domestically.
Introduction
Three years ago we called in this journal for progress on
an interdisciplinary research agenda for law and policy in-
terventions to cope with curbing the non-communicable
disease (NCD) pandemic [1]. Specifically, we argued in
favour of an interaction between law, public health, health
economics and international relations aimed at designing
concrete interventions to curb the NCD pandemic, at na-
tional and international level.
By 2030, NCDs will be the leading cause of death in
every region in the world [2]. Much of the global NCD
burden (40%) is linked to four “modifiable behavioral
risk factors” that affect many countries: tobacco use, un-
healthy diets, physical inactivity and harmful use of alco-
hol [2]. In this context, there is an association between
socio-economic inequalities, NCDs and these risk factors
for NCDs [3]. The scale of the problem makes NCDs a
pandemic phenomenon that requires a powerful inter-
national and domestic response.
Researchers from various disciplinary angles have en-
gaged with NCDs and made a meaningful contribution
to the development of effective NCD laws and policies
[4–7]. However, we observe that interdisciplinary re-
search geared at law and policy-making does not always
receive the support and outreach it deserves. Specifically,
many more efforts and resources should be allocated to
interdisciplinary research endeavours, with implications
for law and policy-making, which, given the magnitude
and complexity of the problem, deserve more attention.
In our Debate piece published in 2017 in this journal
we identified a number of gaps in current research and
called for an interdisciplinary research agenda between
law and other disciplines aimed at designing concrete
proposals for laws and policies to curb the NCD pan-
demic, both globally and domestically [1]. In a subse-
quent call for papers we invited scholars from various
health-related disciplines to submit a paper focusing on
the identification of this research agenda with the aim of
identifying concrete solutions to the NCD pandemic.
The result of this call for papers is the present collection
of articles in BMC International Health and Human
Rights, herewith launched.
This introductory paper sets the stage for this collec-
tion of papers and identifies research approaches from
four disciplinary angles: public health, health economics,
law, and international relations. Through an interaction
between these approaches, we aim to draw some conclu-
sions on these disciplinary dimensions and their inter-
action. We recognise that this selection is by no means
exhaustive of all the disciplinary dimensions to the
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debate. The overall goal of our proposed integrated re-
search agenda is to fill the policy ‘toolbox’ of govern-
ments with evidence-based proposals for sound and
effective law and policy interventions on curbing NCDs.
This type of research needs to be developed in particular
in Low and Middle Income Countries (LMICs), where
little research on NCDs is carried out, in particular when
it comes to evaluating good practice interventions in a
local context [7].
Public health: quantifying the burden and
modifiable risk factors
The first thing that should happen from a public health
perspective, to prevent the creation of ‘solutions without
problems’, is to quantify the disease burden and to
understand the key drivers of NCDs. The Global Burden
of Disease-group (GBD-group) has recently published its
findings on disability-adjusted life-years (DALY) and
healthy life expectancy on a global, regional and national
scale, for a very large number of diseases, including spe-
cifically NCDs [8]. The same GBD-group carried out a
global, regional, and national comparative risk assess-
ment of a large number of risk factors in all countries of
the world [9]. Their study found that out of 34.1 million
deaths, 61% could be attributed to risk factors covered
by the GBD study, and 48.3% of 1.21 billion DALYs. In
terms of leading risk factors, high systolic blood pressure
(SBP) ranked highest (accounting for 10.4 million deaths
and 218 million DALYs), followed by smoking (7.10 mil-
lion deaths and 182 million DALYs), high fasting plasma
glucose (6.53 million deaths and 171 million DALYs)
and high body-mass index (4.72 million deaths and 148
million DALYs). In 2017, this high SBP was the leading
Level 4 risk factor for age-standardised DALY rates in
four super-regions: Central Europe, Eastern Europe, and
Central Asia; North Africa and Middle East; South Asia;
and Southeast Asia, East Asia, and Oceania. Instead,
smoking was the leading risk factor in the high-income
super-regions (Europe and North America), and high
BMI in the Latin America and Caribbean region. Under-
standing key drivers of NCD risk is essential for success-
fully curbing their incidence, and related health risks.
A next step would be forecasting life expectancy, years
of life lost, and all-cause and cause-specific mortality for
a large number of diseases in a large number of coun-
tries and territories with reference and alternative sce-
nario’s [10]. A further related step would be the question
where we are now in curbing NCDs and what should be
done [11].
The WHO currently identifies four NCDs (cardiovas-
cular diseases, cancer, diabetes and chronic respiratory
diseases) as the leading cause of death, with NCDs gen-
erally being responsible for 70% of deaths world-wide. It
also identifies four key modifiable risk factors that
contribute to these four diseases (tobacco use, unhealthy
diet, lack of physical activity, and the harmful use of al-
cohol). According to the WHO, these factors inter alia
“lead to overweight and obesity, raised blood pressure,
and raised cholesterol, and ultimately disease” [12].
The WHO and the international community, including
through UN Sustainable Development Goal 3.4, have
committed to curb the global NCDs epidemic and espe-
cially to reduce premature mortality from NCDs through
prevention and treatment [13]. As it is difficult to de-
crease mortality due to NCDs directly, it seems easier to
indirectly decrease mortality by influencing the modifi-
able behavioural risk factors, like tobacco use, unhealthy
diet, lack of physical activity, and the harmful use of al-
cohol. These behaviours in turn lead to pathological
conditions contributing to NCDs.
WHO has called these modifiable behavioural risk fac-
tors a ‘best buy’. In 2017 and 2020, the WHO has moni-
tored per country the revised set of WHO ‘best-buys’
and other recommended interventions for the preven-
tion and control of NCDs, also endorsed by the World
Health Assembly in May 2017 [12]. The ‘best buys’ cur-
rently consist of 16 practical and cost-effective interven-
tions that can be delivered at the primary level and
include measures like increasing tobacco taxes; restrict-
ing alcohol advertising; reformulating food products with
less salt, sugar and fat; vaccinating girls against cervical
cancer; treating hypertension and diabetes; and more.
They are presented as ‘a powerful economic tool’ in that
the WHO estimates that every dollar invested in them
‘will yield a return of at least seven dollars’, as well as
save 10 million lives by 2025, and prevent 17 million
strokes and heart attacks by 2030 [14]. More expertise
needs to be generated as to how these best buys can best
be transformed into domestic law and policies, in light
of regional and domestic circumstances and demands.
Health economics
The field of economics has several novel contributions
to make to the toolbox for policy interventions, espe-
cially in terms of novel ways with which, in the absence
of randomized controlled trials, something can be said
about the causal relationship between a set of measur-
able quantities, like having suffered from hunger and
health outcomes later on in life [15]. From a policy per-
spective, knowledge of such empirical relationships is
crucial as it assists in developing policies that target the
mechanisms by which (adverse) health outcomes come
about and can contribute to the reduction of the NCD
burden [16].
A good illustration is offered by the early-life determi-
nants of chronic disease burden later in life [17]. Many
studies have, and are still, associating adverse early life
conditions with (chronic) health outcomes in later years
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[18]. Generally, such studies highlight that children who,
for instance, grew up in low-income households go on
to develop a host of health conditions. It is tempting to
design policies aimed at raising income standards, yet
the association only tells half the story. After all, the
question remains whether parents who “generate” a low-
income household simply also “generate” children who
go on to develop all kinds of health problems, regardless
of the low-income household in which they grew up. In
that case boosting incomes - through transfers or sub-
sidies - would not achieve the desired health effect.
Thus, what can, and has been, done? Economists like
to seek out natural experiments - situations in which the
environment around us provides us with a near experi-
mental setting. The fluctuations of the economy provide
such natural experiments [19]. Indeed, comparing two
cohorts, one born during a recession and one just before
or after, provides us with a treatment group (recession
babies) and a control group (babies born in more tran-
quil times). The information load is quite low, a date
and place of birth suffice, the costs are marginal and
there is no ethical component as the researcher him-
self or herself did not cause the recession. These cohorts
would then be checked against prevalent health out-
comes and the analysis can be performed. Working
along these lines, a host of health economic studies have
highlighted that adverse economic conditions early in
life causally affect health outcomes during a person’s life
course. For instance, on birth weight [20], on cardiovas-
cular disease risk [21], on all-cause mortality [22], on de-
mentia [23] and on many others. These results call for a
strong focus on conditions early in life for the preven-
tion of disease late(r) in life.
The above approach focusing on incidents earlier in
life and on health outcomes later in life, illustrates how
health economics can assist in the quest to reduce the
burden of NCDs by unraveling the causal mechanism
that lie underneath the rising NCD epidemic. Most of
the time, the required data already exist.
International relations
As evidence on the NCD disease burden and risk factors
are built, relevant national and international laws and
policies will be necessary to curb, steer, forbid or stimu-
late any (un)desirable behaviour.
Especially in the sphere of NCDs, risk factors are not
affected only by individual behaviour, but also heavily
impacted by the (contradictory) interests and agendas of
major powerful actors such as tobacco, food and bever-
ages, or pharmaceutical industries [24]. For such reason,
sufficiently powerful responses, including in the form of
binding regulations, are necessary. Concerns have been
voiced in particular about the spread of NCDs to and in
developing countries, and the truly global reach of some
multi-national companies marketing harmful products
to (vulnerable) customers. Tackling NCDs globally,
therefore, does not just require action by individual
countries, but international cooperation and sharing of
(best) practices, including for example, on the most ef-
fective implementation of the WHO’s ‘best buys’.
There is already a strong international cooperative
practice available through the first binding treaty on
NCDs: the Framework Convention on Tobacco Control
under auspices of the WHO in 2005. Important lessons
can be drawn from this effort (see further below) [25]. In
fact, over the years, several so far unsuccessful proposals
have been made to replicate the FCTCs regulatory initia-
tive, such as the calls for a Global Convention on
Healthy Diets from 2014 onwards, in response to the
perceived failure of the WHO’s Healthy Diets Strategy
adopted 10 years prior [26], or the failed initiative for a
Global Alcohol Convention in 2006.
Our article of 2017 suggested that successful law and
policy-making in the sphere of NCDs will benefit from
further understanding and insights into how international
(legal) norms may emerge over time, or be met with re-
sistance [1, 25]. In particular, research at the intersections
of international law and international relations will im-
prove our understanding of how formulation and adop-
tion of new legal norms may be shaped through
appropriate framing of problems, solutions and the con-
sistent spread of public messages on NCDs. Or similarly,
may require suitable, powerful ‘norm entrepreneurs’ with
relevant organizational platforms in early phases of norm
development [27, 28]. While the success of any normative
campaign will depend on many different factors, it is ar-
gued that further research into the (successful) framing
and lobbying by anti-tobacco interests groups, as well as
key figures and key countries, may yield valuable insights
into how relevant actors in this sphere worked together
successfully, or were supported or thwarted in their efforts
to achieve (strong) evidence-based law and policy-
intervention.
In recent years, several (comparative) works on global
network-formation around tobacco, alcohol and other
risk factors were published to shed light on such ques-
tions [29, 30]. Such works have inter alia suggested that
the anti-tobacco movement was exceptionally effective
because they developed effectively ‘from a group of dedi-
cated individuals into a strong international coalition’
backed by membership-based organizations (achieved
‘network-formation’), and also succeeded in formulating
and maintaining a widespread consensus about both the
dangers of tobacco, along with the requisite policy mea-
sures to control its use (achieved ‘issue-formulation’ and
fostered ‘scientific closure’ on tobacco harms) [29, 30].
Instead, alcohol control organizations are much more di-
verse and loosely organized group(s) of organisations,
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advancing different problems and solutions around alco-
hol as key concerns, e.g. in the sphere of treating
addition, NCD incidence, alcohol-related violence, or
public health issues, including road-safety [29, 31]. In
short, the alcohol movement may so far lack the same
dedicated ‘coalition-forming’ or ‘network formation’, en-
abling them to formulate a sufficiently effective and
compelling global message on how and why it is import-
ant to more strictly regulate alcohol consumption, in
specific manners.
Overall, such research on the emergence, adoption and
implementation of new global (legal) norms can be found
at the intersections of the disciplines of law, international
relations, and political science, and includes useful analyt-
ical models such as ‘norm-life cycle models’, ‘norm spiral
models’, or theories about ‘transnational legal processes’
or the role of ‘transnational advocacy networks’, pushing
for global norms, but also bringing them home and trans-
lating them into domestic systems [32, 33].
Law as a tool to reduce risk factors
Research supports that law is an important tool to reduce
modifiable behavioural risk factors. A range of proven ef-
fective legal tools are at the disposal of governments to re-
duce smoking, excessive use of alcohol, and the
consumption of unhealthy diets. The above-mentioned
‘best buys’ as developed by WHO offer guidance, as well
as a vast amount of scientific research investigation on the
effectiveness of these legal tools. Such evidence is most
prevalent and convincing in relation to tobacco use and
exposure to second-hand smoke (SHS). For example,
there is ample research underlining that tobacco taxes re-
duce tobacco consumption [34], as well as research prov-
ing the beneficial health effects of smoke-free zones [35].
There are, furthermore, some positive experiences with
taxes on sugar-sweetened beverages [36] and marketing of
unhealthy food products [37].
While legal action on NCDs ultimately has to be im-
plemented by domestic legal systems, adapted to local
circumstances, there is international and regional legisla-
tion that informs domestic states how to regulate the
modifiable risk factors. Again, this legislation is most de-
veloped when it comes to tobacco, through the FCTC.
This treaty, that has been ratified by 181 States, sets
standards in relation to, inter alia, the interaction be-
tween government and the tobacco industry, price and
tax measures, and protection from exposure to tobacco
smoke [38]. It has had considerable impact on domestic
tobacco legislation, in the sense many States Parties have
amended their domestic tobacco legislation in order to
comply with the treaty [39]. Many countries, however,
are lagging behind in their implementation of inter-
national commitments, [40, 41], while other States go
beyond the FCTC by adopting further reaching
measures, for example by prohibiting smoking in cars
when a child is on board [42]. Legal researchers have in-
creasingly begun to analyse what inspires legal compli-
ance or ambitions, and in any case, the reasons or
mechanisms for (non) implementation or (lack of) ambi-
tion deserves further understanding. Legal research will
benefit here from collaborative research with other disci-
plines, such as international relations, political science,
or sociology.
Regulating risk factors touches on a range of values
that are inherent in individual dignity. Such values are
also protected by law in the form of international and
regional human rights standards that provide a legally
binding framework for protecting them, as well as for
balancing the various interests involved [43]. On the one
hand, rights to life, health and information for example
reflect governmental duties to take measures to protect
individuals against the harms caused by risk factors. On
the other hand, measures aimed at modifying behaviours
may imply restrictions of the full freedom someone has
– or at least people perceive to have – including inter-
ventions ‘behind the front door’. Here human rights to
physical integrity, privacy and freedom of movement
come into play. A balancing act between the protection
of health and individual freedom does not always lead to
a clear outcome. Yet it is important to articulate such
values, make them visible, and take them into account
when taking NCD control measures. More efforts can be
made to identify so-called ‘human rights based ap-
proaches’ toward reducing risk factors [33]. Specifically,
a ‘child rights’ approach gives guidance into how the
best interests of children can be protected in the context
of the mentioned risk factors [44].
Finally, human rights law is also a useful framework for
addressing socio-economic conditions that go beyond be-
havioural risk factors. The human rights framework re-
flects the notion that a broad range of social determinants
are crucial for the achievement of good health [45, 46].
Importantly, human rights law does not only inform
sound law and policy making, but is an important vehicle
for accountability of governments and powerful actors,
and can inform agenda-setting. In what contexts human
rights should and can be effectively harnessed is an im-
portant aspect of the NCD research agenda.
Concluding observations
We argue that solutions to the NCD pandemic can be
found, or must necessarily be found, through an inter-
action between various disciplines, including the ones
we identify in this piece. While public health and health
economics identify the data on which new laws and pol-
icies should rest, international relations theory may help
understand or identify the political processes through
which new laws and policies can be promoted and
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adopted, or the types of obstacles or resistance that
could be expected. Through this interaction, sound
NCD laws, policies and other interventions can be iden-
tified that benefit individuals, paying due respect to their
human rights.
Our overview has also revealed some gaps in existing
research. From a public health perspective, more data
can be generated on the disease burden and on modifi-
able risk factors. Economics can enhance our under-
standing of the causal impact of risk factors on health
outcomes as well the impact of various laws, policies
and interventions aimed at curbing the NCD epidemic.
From an international relations and legal perspective,
the feasibility and nature of international and domestic
laws and policies regulating alcohol and diets could be
further explored, especially in light of what is perceived
as (relative) success of the anti-tobacco movement, as
well as the role and potential of human rights in regulat-
ing risk factors. Adequate implementation of laws and
policies will raise a further range of questions, not ad-
dressed so much in this Issue, including questions of tai-
loring interventions to evidence and concerns in specific
domestic contexts, as well as ensuring adequate imple-
mentation, compliance and accountability. In this sense,
we highlight especially the importance of fostering the
right culture, values and mechanisms for accountability
for violations of NCD laws and policies, and of human
rights, including by industry [47].
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